StockNews.com Begins Coverage on Syneos Health (NASDAQ:SYNH)

StockNews.com started coverage on shares of Syneos Health (NASDAQ:SYNH) in a report published on Friday morning. The brokerage issued a hold rating on the stock.

Syneos Health Trading Up 0.1 %

NASDAQ SYNH opened at $42.78 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.20 and a current ratio of 1.20. The company has a 50-day simple moving average of $42.54 and a 200-day simple moving average of $40.52. The firm has a market capitalization of $4.44 billion, a PE ratio of 62.00 and a beta of 1.58. Syneos Health has a one year low of $22.89 and a one year high of $52.23.

Syneos Health (NASDAQ:SYNH) last posted its earnings results on Tuesday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.63). The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.26 billion. Syneos Health had a net margin of 1.31% and a return on equity of 8.63%. On average, equities analysts forecast that Syneos Health will post 2.79 earnings per share for the current year.

Institutional Trading of Syneos Health

A number of hedge funds and other institutional investors have recently made changes to their positions in SYNH. Cetera Advisor Networks LLC raised its position in shares of Syneos Health by 11.1% during the 1st quarter. Cetera Advisor Networks LLC now owns 3,725 shares of the company’s stock worth $302,000 after buying an additional 372 shares in the last quarter. Bank of Montreal Can raised its holdings in shares of Syneos Health by 55.6% in the 1st quarter. Bank of Montreal Can now owns 69,809 shares of the company’s stock worth $5,697,000 after purchasing an additional 24,933 shares in the last quarter. Great West Life Assurance Co. Can raised its holdings in shares of Syneos Health by 8.0% in the 1st quarter. Great West Life Assurance Co. Can now owns 56,664 shares of the company’s stock worth $4,716,000 after purchasing an additional 4,203 shares in the last quarter. Cibc World Market Inc. raised its holdings in shares of Syneos Health by 214.3% during the first quarter. Cibc World Market Inc. now owns 22,133 shares of the company’s stock valued at $1,792,000 after acquiring an additional 15,091 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Syneos Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,042,500 shares of the company’s stock valued at $84,394,000 after acquiring an additional 5,999 shares during the period. 91.16% of the stock is currently owned by institutional investors.

About Syneos Health

Syneos Health, Inc, operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development.